Genzyme is committed to discovering and delivering transformative therapies for patients with rare and special unmet medical needs, providing hope where there was none before. Genzyme has pioneered the development and delivery of transformative therapies for over 30 years. Founded in 1981 in Boston, Massachusetts, Genzyme evolved from a tiny start-up with just a handful of employees to one of the world's leading biotech companies. Acquired by Sanofi in 2011, Genzyme now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients. Genzyme has long been known for our expertise in the class of rare genetic diseases known as lysosomal storage disorders (LSDs). LSDs remain the heart of our company today, but we have also expanded – through both in-house development and strategic acquisitions and partnerships – to other disease areas such as thyroid cancer and multiple sclerosis. Driven by our commitment to patients, we strive to develop strong relationships with patient communities and listen to their perspectives so that we can truly understand their needs. These collaborations guide us as we continue to push the boundaries of medicine and technology to develop new and better therapies where none existed before.
View Top Employees from Genzyme Europe B.V.Website | http://www.genzyme.com |
Revenue | $4.5 billion |
Employees | 306 (159 on RocketReach) |
Founded | 1981 |
Phone | (617) 252-7500 |
Fax | (617) 252-7600 |
Industry | Biotechnology Research, Pharmaceuticals, Healthcare, Biotechnology, Drug Manufacturing & Research, Medical Devices & Equipment, Manufacturing |
Keywords | Rare Disease, Biotechnology, Pharmaceutical Companies, Multiple Sclerosis, Medical Technologies |
SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 2834 Companies, SIC Code 2836 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 325412 Companies, NAICS Code 325414 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Genzyme Europe B.V. employee's phone or email?
The Genzyme Europe B.V. annual revenue was $4.5 billion in 2024.
Anne-Marie Li-Kwai-Cheung is the Director EU Regulatory Affairs of Genzyme Europe B.V..
159 people are employed at Genzyme Europe B.V..
The NAICS codes for Genzyme Europe B.V. are [32541, 325412, 325414, 32, 325, 3254].
The SIC codes for Genzyme Europe B.V. are [283, 28, 2834, 2836].